(Q42445360)

31 October 2017

title

Influence of acth on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer (English)

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

3 August 2023

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

3 August 2023

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

3 August 2023

author name string

P. F. Bruning

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6092781

3 August 2023

J. M. Bonfrer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6092781

3 August 2023

M. De Jong-Bakker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6092781

3 August 2023

W. Nooyen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6092781

3 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6092781

3 August 2023

publication date

1 September 1984

1 reference

full work available at URL

31 October 2017

https://api.elsevier.com/content/article/PII:0022473184902826?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

https://api.elsevier.com/content/article/PII:0022473184902826?httpAccept=text/plain

3 August 2023

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

The Journal of Steroid Biochemistry

3 August 2023

published in

1 reference

31 October 2017

volume

21

1 reference

31 October 2017

issue

3

1 reference

31 October 2017

page(s)

293-298

1 reference

A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer

31 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

3 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function

3 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Tamoxifen therapy in premenopausal patients with metastatic breast cancer

3 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action.

3 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Aminoglutethimide Inhibition of Adrenal Desmolase Activity

3 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration

3 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

3 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Preliminary trial of aminoglutethimide in breast cancer

3 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Adrenal Suppression with Aminoglutethimide. I. Differential Effects of Aminoglutethimide on Glucocorticoid Metabolism as a Rationale for Use of Hydrocortisone12

3 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Conversion of androstenedione to estrone by human tissue.

3 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Aromatization of Androgens by Human Abdominal and Breast Fat Tissue1

3 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

3 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Pros and cons of aminoglutethimide for advanced postmenopausal breast cancer

3 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Serum Aminoglutethimide Levels: Studies of Serum Half-Life, Clearance, and Patient Compliance

3 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

The determination of cortisol in human plasma: evaluation and comparison of seven assays

3 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Plasma and urinary androgens in women with varying degrees of risk of breast cancer

3 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Plasma oestradiol and progesterone levels in women with varying degrees of risk of breast cancer

3 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Characterisation of monoclonal antibodies raised against testosterone

3 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

The measurement of 5-androstene-3 beta, 17 beta-diol in plasma by radioimmunoassay

3 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Adrenal Suppression with Aminoglutethimide. III. Comparison of Plasma Δ4- and Δ5-Steroids in Postmenopausal Women Treated for Breast Carcinoma*

3 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer

3 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0022-4731(84)90282-6

3 August 2023

Identifiers

1 reference

31 October 2017

1 reference